Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (22.499)

31

Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19 : Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19

enthalten in: ClinicalTrials.gov | 2024

32

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis : Open Label Phase 2 Clinical Study of Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

enthalten in: ClinicalTrials.gov | 2024

33

COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Henderson, H. | Wohl, D. | Fischer, W. | +8

34

Different effects of the companion antiretroviral drugs on dolutegravir trough concentrations

enthalten in: AIDS (London, England) | 2024

von Cattaneo, D. | Pagano, S. | Colombo, M. | +3

35

Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa

enthalten in: Clinical pharmacology and therapeutics | 2024

von Chupradit, S. | Wamalwa, D. | Maleche-Obimbo, E. | +11

36

Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice

enthalten in: Molecular pharmaceutics | 2024

von Loos, N. | Ferreira Martins, M. | Rijmers, J. | +5

37

The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance

enthalten in: Antiviral research | 2024

von Schreiber, A. | Rodner, F. | Oberberg, N. | +5

38

Nirmatrelvir and ritonavir combination against COVID-19 caused by omicron BA.2.2 in the elderly : A single-center large observational study

enthalten in: Immunity, inflammation and disease | 2024

von Chen, C. | Li, R. | Xing, S. | +5

39

Baloxavir-marboxil/nirmatrelvir+ritonavir

enthalten in: Reactions weekly | 2024

40

COVID-19-vaccine/nirmatrelvir+ritonavir/tacrolimus

enthalten in: Reactions weekly | 2024